Cited by 229Bacterial Cancer TherapyAmino Acid Enzymes and MetabolismCancer, Hypoxia, and Metabolism

The DOI matches its Crossref record; 105 of the 105 references it cites were found in a registry or an index.

Targeting Arginine-Dependent Cancers with Arginine-Degrading Enzymes: Opportunities and Challenges

Open access

Phillips, Melissa M., Sheaff, Michael T., Szlosarek, Peter W.·2013·Cancer Research and Treatment

DOI 10.4143/crt.2013.45.4.251PMC PMC3893322

Open this paper in CoChat — free account Open PDF

Abstract

Arginine deprivation is a novel antimetabolite strategy for the treatment of arginine-dependent cancers that exploits differential expression and regulation of key urea cycle enzymes. Several studies have focused on inactivation of argininosuccinate synthetase 1 (ASS1) in a range of malignancies, including melanoma, hepatocellular carcinoma (HCC), mesothelial and urological cancers, sarcomas, and lymphomas. Epigenetic silencing has been identified as a key mechanism for loss of the tumor suppressor role of ASS1 leading to tumoral dependence on exogenous arginine. More recently, dysregulation of argininosuccinate lyase has been documented in a subset of arginine auxotrophic glioblastoma multiforme, HCC and in fumarate hydratase-mutant renal cancers. Clinical trials of several arginine depletors are ongoing, including pegylated arginine deiminase (ADI-PEG20, Polaris Group) and bioengineered forms of human arginase. ADI-PEG20 is furthest along the path of clinical development from combinatorial phase 1 to phase 3 trials and is described in more detail. The challenge will be to identify tumors sensitive to drugs such as ADI-PEG20 and integrate these agents into multimodality drug regimens using imaging and tissue/fluid-based biomarkers as predictors of response. Lastly, resistance pathways to arginine deprivation require further study to optimize arginine-targeted therapies in the oncology clinic.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.4143/crt.2013.45.4.251

Cites

105 of 105 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
mTOR Signaling in Growth Control and Disease
Laplante, M., & Sabatini, D. M. (2012) · Cell · doi:10.1016/j.cell.2012.03.017 · Cited by 8,509
Arginine metabolism: nitric oxide and beyond
WU, G., & MORRIS, S. M. (1998) · Biochemical Journal · doi:10.1042/bj3360001 · Cited by 2,811
Functional genomics reveal that the serine synthesis pathway is essential in breast cancer
Possemato, R., Marks, K. M., Shaul, Y. D., Pacold, M. E., Kim, D., Birsoy, K., Sethumadhavan, S., Woo, H.-K., Jang, H. G., Jha, A. K., et al. (2011) · Nature · doi:10.1038/nature10350 · Cited by 1,683
Macropinocytosis of protein is an amino acid supply route in Ras-transformed cells
Commisso, C., Davidson, S. M., Soydaner-Azeloglu, R. G., Parker, S. J., Kamphorst, J. J., Hackett, S., Grabocka, E., Nofal, M., Drebin, J. A., Thompson, C. B., et al. (2013) · Nature · doi:10.1038/nature12138 · Cited by 1,683
Femtomole sequencing of proteins from polyacrylamide gels by nano-electrospray mass spectrometry
Wilm, M., Shevchenko, A., Houthaeve, T., Breit, S., Schweigerer, L., Fotsis, T., & Mann, M. (1996) · Nature · doi:10.1038/379466a0 · Cited by 1,674
Targeting cancer metabolism: a therapeutic window opens
Heiden, M. G. V. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3504 · Cited by 1,443
Arginase-Producing Myeloid Suppressor Cells in Renal Cell Carcinoma Patients: A Mechanism of Tumor Evasion
Zea, A. H., Rodrı́guez, P. C., Atkins, M. B., Hernandez, C., Signoretti, S., Zabaleta, J., McDermott, D. F., Quiceno, D. G., Youmans, A. J., O’Neill, A., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4505 · Cited by 852
Recent advances in arginine metabolism: roles and regulation of the arginases
Morris Jr, S. M. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00278.x · Cited by 485
Evidence that the L-Asparaginase Activity of Guinea Pig Serum is responsible for its Antilymphoma Effects
Broome, J. D. (1961) · Nature · doi:10.1038/1911114a0 · Cited by 461

Flagged first, then by citations

Show all 105 references

Sorted by citations

Items 101–200 of 229

Dietary intervention as a therapeutic for cancer
Morita, M., Kudo, K., Shima, H., & Tanuma, N. (2020) · Cancer Science · doi:10.1111/cas.14777 · Cited by 25
Gas6/Axl is the sensor of arginine-auxotrophic response in targeted chemotherapy with arginine-depleting agents
Tsai, W.-B., Long, Y., Park, J.-R., Chang, J. T., Liu, H., Rodriguez‐Canales, J., Savaraj, N., Feun, L. G., Davies, M. A., Wistuba, I. I., et al. (2015) · Oncogene · doi:10.1038/onc.2015.237 · Cited by 24
Metabolic mechanisms of immunotherapy resistance
Cabezón‐Gutiérrez, L., Palka-Kotlowska, M., Custodio‐Cabello, S., Chacón-Ovejero, B., & Pacheco-Barcía, V. (2025) · Exploration of Targeted Anti-tumor Therapy · doi:10.37349/etat.2025.1002297 · Cited by 26
Dysregulated Alanine as a Potential Predictive Marker of Glioma—An Insight from Untargeted HRMAS-NMR and Machine Learning Data
Firdous, S., Abid, R., Nawaz, Z., Bukhari, F., Anwer, A., Cheng, L. L., & Sadaf, S. (2021) · Metabolites · doi:10.3390/metabo11080507 · Cited by 22
Selective extracellular arginine deprivation by a single injection of cellular non-uptake arginine deiminase nanocapsules for sustained tumor inhibition
Qi, H., Wang, Y., Yuan, X., Li, P., & Yang, L. (2020) · Nanoscale · doi:10.1039/d0nr06823c · Cited by 24
TRAIL stabilization and cancer cell sensitization to its pro-apoptotic activity achieved through genetic fusion with arginine deiminase
Brin, E., Wu, K., Dagostino, E., Kuo, M. M.-C., He, Y., Shia, W.-J., Chen, L.-C., Stempniak, M., Hickey, R., Almassy, R. J., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.26398 · Cited by 21
Arginine Deiminase: Current Understanding and Applications
Zarei, M., Rahbar, M. R., Morowvat, M. H., Nezafat, N., Negahdaripour, M., Berenjian, A., & Ghasemi, Y. (2018) · Recent Patents on Biotechnology · doi:10.2174/1872208313666181220121400 · Cited by 21
Systems level profiling of arginine starvation reveals MYC and ERK adaptive metabolic reprogramming
Brashears, C. B., Barlin, M., Ehrhardt, W. R., Rathore, R., Schultze, M., Tzeng, S.-C., Tine, B. A. V., & Held, J. M. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-02899-8 · Cited by 21
Targeting cancer metabolism at the plasma membrane by limiting amino acid access through SLC6A14
McCracken, A. N., & Edinger, A. L. (2015) · Biochemical Journal · doi:10.1042/bj20150721 · Cited by 19
Arginine Depletion by Arginine Deiminase Does Not Affect Whole Protein Metabolism or Muscle Fractional Protein Synthesis Rate in Mice
Marini, J. C., & Didelija, I. C. (2015) · PLoS ONE · doi:10.1371/journal.pone.0119801 · Cited by 19
The effect of l-arginine supplementation and surgical trauma on the frequency of myeloid-derived suppressor cells and T lymphocytes in tumour and blood of colorectal cancer patients
Szefel, J., Ślebioda, T. J., Walczak, J., Kruszewski, W. J., Szajewski, M., Ciesielski, M., Stanisławowski, M., Buczek, T., Małgorzewicz, S., Owczarzak, A., et al. (2022) · Advances in Medical Sciences · doi:10.1016/j.advms.2021.12.005 · Cited by 19
Phase 1, pharmacogenomic, dose‐expansion study of pegargiminase plus pemetrexed and cisplatin in patients with ASS1‐deficient non‐squamous non‐small cell lung cancer
Szlosarek, P. W., Wimalasingham, A. G., Phillips, M. M., Hall, P. E., Chan, P. Y., Conibear, J., Lim, L., Rashid, S., Steele, J. P. C., Wells, P., et al. (2021) · Cancer Medicine · doi:10.1002/cam4.4196 · Cited by 17
Self-citation
Target Therapy in Malignant Pleural Mesothelioma: Hope or Mirage?
Borea, F., Frańczak, M. A., Garcia, M., Perrino, M., Cordua, N., Smoleński, R., Peters, G., Dziadziuszko, R., Santoro, A., Zucali, P., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119165 · Cited by 15
Tissue metabolic profiling of lymph node metastasis of colorectal cancer assessed by 1H NMR
Zhang, H., Qiao, L., Li, X., Wan, Y., Yang, L., & Wang, H. (2016) · Oncology Reports · doi:10.3892/or.2016.5175 · Cited by 17
Plasma amino acids indicate glioblastoma with ATRX loss
Bobeff, E. J., Szczęsna, D., Bieńkowski, M., Janczar, K., Chmielewska-Kassassir, M., Wiśniewski, K., Papierz, W., Woźniak, L. A., & Jaskólski, D. J. (2021) · Amino Acids · doi:10.1007/s00726-020-02931-3 · Cited by 17
Construction and in vitro evaluation of enzyme nanoreactors based on carboxymethyl chitosan for arginine deprivation in cancer therapy
Zeng, T., Zhang, Y., Yan, Q., Huang, Z., Zhang, L., Yi, X., Chen, J., He, G., & Yin, Y. (2017) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2017.01.023 · Cited by 17
Arginine Deprivation in SCLC: Mechanisms and Perspectives for Therapy
Carpentier, J., Pavlyk, I., Mukherjee, U., Hall, P. E., & Szlosarek, P. W. (2022) · Lung Cancer Targets and Therapy · doi:10.2147/lctt.s335117 · Cited by 16
Self-citation
Combinatory Treatment of Canavanine and Arginine Deprivation Efficiently Targets Human Glioblastoma Cells via Pleiotropic Mechanisms
Karatsai, O., Shliaha, P. V., Jensen, O. N., Stasyk, O. V., & Rędowicz, M. J. (2020) · Cells · doi:10.3390/cells9102217 · Cited by 14
Human arginase 1, a Jack of all trades?
Anakha, J., Kawathe, P. S., Datta, S., Jawalekar, S. S., Banerjee, U. C., & Pande, A. H. (2022) · 3 Biotech · doi:10.1007/s13205-022-03326-9 · Cited by 18
Cationic amino acid transporter-1 (CAT-1) promotes fibroblast-like synoviocyte proliferation and cytokine secretion by taking up L-arginine in rheumatoid arthritis
Lü, Y., Hao, C., Yu, S., Ma, Z., Fu, X., Qin, M., Ding, M., Xu, Z., & Fan, L. (2022) · Arthritis Research & Therapy · doi:10.1186/s13075-022-02921-8 · Cited by 16
Arginine Deiminase Induces Immunogenic Cell Death and Is Enhanced by N-acetylcysteine in Murine MC38 Colorectal Cancer Cells and MDA-MB-231 Human Breast Cancer Cells In Vitro
Huang, Z., & Hu, H. (2021) · Molecules · doi:10.3390/molecules26020511 · Cited by 17
Chronic Stress Blocks the Endometriosis Immune Response by Metabolic Reprogramming
Lu, C., Xu, J., Li, K., Wang, J., Dai, Y., Chen, Y., Chai, R., Xu, C., & Kang, Y. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms25010029 · Cited by 16
Argininosuccinate Synthetase-1 (ASS1) Loss in High-Grade Neuroendocrine Carcinomas of the Urinary Bladder: Implications for Targeted Therapy with ADI-PEG 20
Gupta, S., Sahu, D., Bomalaski, J. S., Frank, I., Boorjian, S. A., Thapa, P. B., Cheville, J. C., & Hansel, D. E. (2018) · Endocrine Pathology · doi:10.1007/s12022-018-9516-9 · Cited by 15
Amino Acid Uptake Measured by [18F]AFETP Increases in Response to Arginine Starvation in ASS1-Deficient Sarcomas
Prudner, B. C., Sun, F., Kremer, J. C., Xu, J., Huang, C., Sai, K. K. S., Morgan, Z., Leeds, H., McConathy, J., & Tine, B. A. V. (2018) · Theranostics · doi:10.7150/thno.22083 · Cited by 14
Decreased argininosuccinate synthetase expression in Thai patients with cholangiocarcinoma and the effects of ADI‑PEG20 treatment in CCA cell lines
Roeksomtawin, S., Navasumrit, P., Waraprasit, S., Parnlob, V., Sricharunrat, T., Bhudhisawasdi, V., Savaraj, N., & Ruchirawat, M. (2018) · Oncology Letters · doi:10.3892/ol.2018.8807 · Cited by 14
Metal ions-induced stability and function of bimetallic human arginase-I, a therapeutically important enzyme
Sadarangani, V., Rahman, S., & Sau, A. K. (2018) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2018.08.006 · Cited by 14
Rational design, engineer, and characterization of a novel pegylated single isomer human arginase for arginine depriving anti-cancer treatment
Yu, K.-M., Pang, T. P. S., Cutler, M. J., Tian, M., Huang, L. Y. L., Lau, J. Y., Chung, S., Lo, T. W.-H., & Leung, T. Y.-C. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118674 · Cited by 14
L-arginase from Streptomyces diastaticus MAM5 as a potential therapeutic agent in breast cancer: Purification, characterization, G1 phase arrest and autophagy induction
Hassabo, A. A., Abdelraof, M., & Allam, R. M. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.10.152 · Cited by 14
Co-application of canavanine and irradiation uncouples anticancer potential of arginine deprivation from citrulline availability
Kurlishchuk, Y. V., Vynnytska‐Myronovska, B., Grosse‐Gehling, P., Bobak, Y. P., Manig, F., Chen, O., Merker, S. R., Henle, T., Löck, S., Stange, D. E., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.12320 · Cited by 14
PRMT7 Interacts with ASS1 and Citrullinemia Mutations Disrupt the Interaction
Verma, M., Charles, R. C. M., Chakrapani, B., Coumar, M. S., Govindaraju, G., Rajavelu, A., Chavali, S., & Dhayalan, A. (2017) · Journal of Molecular Biology · doi:10.1016/j.jmb.2017.05.026 · Cited by 14
Metabolic Adaptations in Cancer Progression: Optimization Strategies and Therapeutic Targets
Dominiak, A., Chełstowska, B., & Nowicka, G. (2025) · Cancers · doi:10.3390/cancers17142341 · Cited by 15
Enterococci for human health: A friend or foe?
Wang, Y., Xu, W., Guo, S., Xu, S., Wang, J., Zhang, S., Kuang, Y., & Jin, P. (2025) · Microbial Pathogenesis · doi:10.1016/j.micpath.2025.107381 · Cited by 17
Drug target identification at the crossroad of neuronal apoptosis and survival
Maino, B., Paparone, S., Severini, C., Ciotti, M. T., D’Agata, V., Calissano, P., & Cavallaro, S. (2017) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2017.1280023 · Cited by 12
Metabolic Alterations in Preneoplastic Development Revealed by Untargeted Metabolomic Analysis
Myllymäki, H., Johansson, J. A., Porro, E. G., Elliot, A. M., Moses, T., & Feng, Y. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.684036 · Cited by 12
Argininosuccinate synthetase (ASS) deficiency in high-grade pulmonary neuroendocrine carcinoma: an opportunity for personalized targeted therapy
Walts, A. E., Bomalaski, J. S., Ines, D., & Oršulić, S. (2014) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-014-1904-z · Cited by 12
The Citrulline Recycling Pathway Sustains Cardiovascular Function in Arginine-Depleted Healthy Mice, but Cannot Sustain Nitric Oxide Production during Endotoxin Challenge
Yuan, Y., Mohammad, M. A., Betancourt, A., Didelija, I. C., Yallampalli, C., & Marini, J. C. (2018) · Journal of Nutrition · doi:10.1093/jn/nxy065 · Cited by 12
Exercise May Affect Metabolism in Cancer-Related Cognitive Impairment
Shahid, M., & Kim, J. (2020) · Metabolites · doi:10.3390/metabo10090377 · Cited by 14
Arginine addiction in AML
Plunkett, W. K. (2015) · Blood · doi:10.1182/blood-2015-05-643411 · Cited by 12
Amino acids in hematologic malignancies: Current status and future perspective
Wang, M., Zhao, A., Li, M., & Niu, T. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1113228 · Cited by 11
Enzyme Cascade with Horseradish Peroxidase Readout for High-Throughput Screening and Engineering of Human Arginase-1
de Santaella, J. F., Ren, J., Vanella, R., & Nash, M. A. (2023) · Analytical Chemistry · doi:10.1021/acs.analchem.2c05429 · Cited by 11
Metabolic characteristics in hepatocellular carcinoma: amino acid metabolic reprogramming
Zhou, R., Li, Y., Li, G., Li, Y., Luo, L., Wang, B., & Wang, L. (2026) · Molecular Cancer · doi:10.1186/s12943-025-02492-7 · Cited by 11
Arginine transportation mechanism through cationic amino acid transporter 1: insights from molecular dynamics studies
Afshinpour, M., & Mahdiuni, H. (2023) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2023.2175374 · Cited by 10
Subspecies of the human gut microbiota carry implicit information for in-depth microbiome research
Tričković, M., Kieser, S., Zdobnov, E. M., & Trajkovski, M. (2025) · Cell Host & Microbe · doi:10.1016/j.chom.2025.07.015 · Cited by 11
The emerging roles of the urea cycle in tumor microenvironment and therapies
Zhou, J., Sun, X., & Jiang, P. (2025) · Trends in cancer · doi:10.1016/j.trecan.2025.08.007 · Cited by 9
Targeting Metabolic Reprogramming in Tumor: From Mechanisms to Precision Immunotherapies
Zhang, T., Gao, P., & Sun, L. (2025) · MedComm – Oncology · doi:10.1002/mog2.70045 · Cited by 10
Inhibition of HSP90 in Driver Oncogene-Defined Lung Adenocarcinoma Cell Lines: Key Proteins Underpinning Therapeutic Efficacy
Marrugal, Á., Ferrer, I., Quintanal-Villalonga, À., Ojeda, L., Pastor, M. D., García‐Luján, R., Carnero, A., Paz-Ares, L. G., & Molina‐Pinelo, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241813830 · Cited by 8
Technetium-99m complexes of l -arginine derivatives for targeting amino acid transporters
Morais, M., Ferreira, V. F. C., Figueira, F., Mendes, F., Raposinho, P., Santos, I., Oliveira, B. L., & Correia, J. D. G. (2017) · Dalton Transactions · doi:10.1039/c7dt01146f · Cited by 8
Modulation of Immuno-biome during Radio-sensitization of Tumors by Glycolytic Inhibitors
Gupta, S., & Dwarakanath, B. S. R. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867325666180601101145 · Cited by 8
Development of cancer prognostic signature based on pan-cancer proteomics
Huang, W., Chen, J., Weng, W., Xiang, Y., Shi, H., & Shan, Y. (2020) · Bioengineered · doi:10.1080/21655979.2020.1847398 · Cited by 8
Human arginase I: a potential broad-spectrum anti-cancer agent
Anakha, J., Prasad, Y. R., Sharma, N., & Pande, A. H. (2023) · 3 Biotech · doi:10.1007/s13205-023-03590-3 · Cited by 9
Advances in the impact of ASS1 dysregulation on metabolic reprogramming of tumor cells
Xia, J., Liu, W., Ni, Y., Shahzad, A., Cui, K., Xu, Z., Zhang, J., Wei, Z., Teng, Z., Yang, Z., et al. (2025) · Cellular Signalling · doi:10.1016/j.cellsig.2025.111593 · Cited by 7
Targeting amino acid in tumor therapy
Ge, M., Xu, Y., Cui, L., Huang, E., Liu, Z., & Yin, K. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1582116 · Cited by 8
The impact of metabolic reprogramming in hepatocellular carcinoma on T cell
Liao, D., An, X., Huang, G., & Yuan, T.-L. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1696113 · Cited by 9
Purification and characterization of L-arginine deiminase from Penicillium chrysogenum
El-Shora, H. M., El-Zawawy, N. A., El-Rheem, M. A. A., & Metwally, M. A. (2024) · BMC Microbiology · doi:10.1186/s12866-024-03192-w · Cited by 7
Inhibition of Tumor Microenvironment-Driven JAK-STAT Signaling Enhances Response to Arginine Deprivation Therapy in Triple-Negative Breast Cancer
Tishler, H., Ziman, S., Cheng, K., Wang, K., Sanghvi, N., Adler, L. N., Stelzer, G., Maniriho, H., Dassa, B., Bab-Dinitz, E., et al. (2025) · Cells · doi:10.3390/cells15010025 · Cited by 6
Nano-medicine therapy reprogramming metabolic network of tumour microenvironment: new opportunity for cancer therapies
Zhang, X., An, M., Zhang, J., Zhao, Y., & Liu, Y. (2024) · Journal of drug targeting · doi:10.1080/1061186x.2024.2309565 · Cited by 6
Metabolomic profiling of plasma from glioma and meningioma patients based on two complementary mass spectrometry techniques
Godlewski, A., Mojsak, P., Pienkowski, T., Łysoń, T., Mariak, Z. D., Reszeć, J., Kamiński, K. A., Moniuszko, M., Kretowski, A. J., & Ciborowski, M. (2025) · Metabolomics · doi:10.1007/s11306-025-02231-5 · Cited by 6
Comparative proteome analysis across non-small cell lung cancer cell lines
Grundner‐Culemann, K., Dybowski, J. N., Klammer, M., Tebbe, A., Schaab, C., & Daub, H. (2015) · Journal of Proteomics · doi:10.1016/j.jprot.2015.09.003 · Cited by 7
The free amino acid profiles and metabolic biomarkers of predicting the chemotherapeutic response in advanced sarcoma patients
Jia, B., Wang, W., Lin, S., Shi, L., Li, Y., Gu, Y., Gao, F., & Qin, Y. (2020) · Clinical & Translational Oncology · doi:10.1007/s12094-020-02494-5 · Cited by 6
Engineering Therapeutic Enzymes
Lutz, S., Williams, E., & Muthu, P. (2017) · Springer eBooks · doi:10.1007/978-3-319-50413-1_2 · Cited by 6
A role for macrophages under cytokine control in mediating resistance to ADI-PEG20 (pegargiminase) in ASS1-deficient mesothelioma
Phillips, M. M., Pavlyk, I., Allen, M. D., Ghazaly, E. A., Cutts, R. J., Carpentier, J., Berry, J. S., Nattress, C. B., Feng, S., Halldén, G., et al. (2023) · Pharmacological Reports · doi:10.1007/s43440-023-00480-6 · Cited by 5
Self-citation
Therapeutic interventions to disrupt the protein synthetic machinery in melanoma
Kardos, G. R., & Robertson, G. P. (2015) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12391 · Cited by 5
Exploring conserved mRNA-miRNA interactions in colon and lung cancers.
Izadi, F., Azodi, M. Z., Mansouri, V., Khodadoostan, M., & Naderi, N. (2017) · Gastroenterology and hepatology from bed to bench. · Cited by 5
Role of 3'-Deoxy-3'-[18F] Fluorothymidine Positron Emission Tomography-Computed Tomography as a Predictive Biomarker in Argininosuccinate Synthetase 1-Deficient Thoracic Cancers Treated With Pegargiminase
Szyszko, T. A., Dunn, J., Phillips, M. M., Bomalaski, J. S., Sheaff, M. T., Ellis, S., Pike, L. C., Goh, V., Cook, G., & Szlosarek, P. W. (2022) · JTO Clinical and Research Reports · doi:10.1016/j.jtocrr.2022.100382 · Cited by 5
Self-citation
A transgenic approach to study argininosuccinate synthetase gene expression
Shiue, S.-C., Huang, M.-Z., & Su, T. (2014) · Journal of Biomedical Science · doi:10.1186/1423-0127-21-42 · Cited by 5
Arginine and colorectal cancer: Exploring arginine-related therapeutic strategies and novel insights into cancer immunotherapies
Jin, K., Chu, X., & Qian, J. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.114146 · Cited by 4
Pegylated arginine deiminase depletes plasma arginine but maintains tissue arginine availability in young pigs
Mohammad, M. A., Didelija, I. C., Stoll, B., Nguyen, T. C., & Marini, J. C. (2021) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00472.2020 · Cited by 4
DNA Methylation and Anticancer Drug Resistance in Gynecological Tumors
Schwarzenbach, H., & Gahan, P. B. (2022) · Cancer Screening and Prevention · doi:10.14218/csp.2022.00004 · Cited by 4
The Dual Role of Autophagy in Cancer: Mechanisms and Therapeutic Strategies
Gao, X.-Z., Qin, Y., Wan, H., Lu, G. X., & Shen, H. (2026) · MedComm – Oncology · doi:10.1002/mog2.70064 · Cited by 3
GC/MS-based differential metabolic profiling of human peptic ulcer disease to study Helicobacter pylori-induced metabolic perturbations
Gupta, G., BANSAL, D., SHARMA, A., Ahmad, T., Sachdev, A., AHMAD, A., EL-SEREHY, H. A., & Kaur, B. (2021) · Biocell · doi:10.32604/biocell.2021.015411 · Cited by 3
Enhancement of anti-tumor activity in melanoma using arginine deiminase fused with 30Kc19α protein
Lee, H., Park, G., Kim, S., Son, B., Joo, J., Park, H. H., & Park, T. H. (2022) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-022-12218-0 · Cited by 3
Proliferation of sphere-forming hepatocellular carcinoma cells is suppressed in a medium without glucose and arginine, but with galactose and ornithine
Tomizawa, M., Shinozaki, F., Motoyoshi, Y., Sugiyama, T., Yamamoto, S., & Ishige, N. (2017) · Oncology Letters · doi:10.3892/ol.2017.5565 · Cited by 3
Tumor starvation by L-arginine deprivation
Fried, R., Carlton, R. M., & Fried, D. A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-824013-7.00005-5 · Cited by 2
Cell metabolomics study on synergistic anti‐hepatocellular carcinoma effect of Aidi injection combined with doxorubicin
Wang, Y., Zhu, X., Wang, K., Cai, Y., Liu, C., Pan, J., Sun, J. M., Liu, T., Huang, Y., Li, Y., et al. (2022) · Biomedical Chromatography · doi:10.1002/bmc.5451 · Cited by 2
The differential regulation of the urea cycle in tumors goes awry
Abou‐Shanab, A. M., Khedr, M. A., & Matosevic, S. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.117365 · Cited by 3
Targeting Cancer Metabolism Dependencies
Harding, K. (2023) · CABI eBooks · doi:10.1079/9781789245820.0004 · Cited by 2
Cellular Serpents and Dreaming Spires: New Frontiers in Arginine and Pyrimidine Biology
Aughey, G., Tastan, Ö. Y., & Liu, J. (2014) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2014.08.006 · Cited by 2
Biological and Clinical Evidence for Metabolic Dormancy in Solid Tumors Post Therapy
Nabavi, N., Ettinger, S., Crea, F., Wang, Y. Z., & Collins, C. C. (2017) · Cancer drug discovery and develogment/Cancer drug discovery and development · doi:10.1007/978-3-319-59242-8_2 · Cited by 2
Metabolic dysregulation in cancer progression
Arfin, S., Agrawal, K., Kumar, A., Kumar, A. J., Rathi, B., & Kumar, D. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-99879-6.00008-0 · Cited by 2
IMMUNOSUPPRESSIVE EFFECTS OF ARGININE DEIMINASE FROM STREPTOCOCCUS PYOGENES
Старикова, Э. А., Av, S., Burova, L. A., & Is, F. (2015) · Medical Immunology (Russia) · doi:10.15789/1563-0625-2015-4-303-318 · Cited by 2
l-Arginine-Incorporated Albumin Mesospheres: A Drug Delivery System for Cancer Therapy
Lee, H.-Y., Mohammed, K. A., & Nasreen, N. (2016) · Springer eBooks · doi:10.1007/978-3-319-26009-9_41 · Cited by 2
Arginine Metabolism: An Enlightening Therapeutic Attribute for Cancer Treatment
Narayan, K. S., & Kashyap, R. (2021) · BiblioBoard Library Catalog (Open Research Library) · doi:10.5772/intechopen.97254 · Cited by 1
Endogenous gut microbiome and implanted intranasal E. coli-Nissle modulate cancer tissues metabolism in 4T1 syngeneic tumor bearing mice
Cecil, A., Gentschev, I., Prehn, C. P., Hauck, S. M., Witting, M. A., Petrov, I. S., Ye, M., Othman, E. M., & Szalay, A. A. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118750 · Cited by 1
Extreme Gradient Boosting with Synthetic Minority Over Sampling Technique for an Improved Breast Cancer Prediction
Rey, A. X., Wahiman, A., Atasan, F., Lumacad, G. S., Bustamante, S. C., & Glanida, R. (2023) · International Conference in Advances in Power, Signal, and Information Technology (APSIT) · doi:10.1109/apsit58554.2023.10201666 · Cited by 1
Expression profile and down-regulation of argininosuccinate synthetase in hepatocellular carcinoma in a transgenic mouse model
Shiue, S.-C., Huang, M.-Z., Tsai, T., Chang, A. C., Choo, K., Huang, C.-J., & Su, T. (2015) · Journal of Biomedical Science · doi:10.1186/s12929-015-0114-6
l-Arginine and Its Transporters in Colorectal Cancer
Chen, B.-G., Wang, W., Ding, K., Wang, J., Gao, P., Xu, G., & Hu, H. (2016) · Springer eBooks · doi:10.1007/978-3-319-26009-9_19
Erythrocytes By-Products of l-Arginine Catabolism
Contreras-Zentella, M. L., & Hernández-Muñoz, R. E. (2016) · Springer eBooks · doi:10.1007/978-3-319-26009-9_8
Chemotherapy and alternative therapies for malignant pleural mesothelioma
Crivellari, S., Ugo, F., Trincheri, N. F., Roveta, A., Randi, L., Libener, R., Ferretti, G., Degiovanni, D., Zai, S., & Grosso, F. (2015) · Working Paper of Public Health · doi:10.4081/wpph.2015.6700
Targeting arginine auxotrophy in pancreatic cancer cells using human recombinant arginase I-induced arginine deprivation
Khalil, N. (2017) · doi:10.26756/th.2017.5
Effect of combined arginase and nitric oxide donor treatment on normal and leukemic cells in vitro
Chen, O. I., Barska, M., Lyniv, L., Igumentseva, N. I., Igumentseva, Vovk, O. I., Sybirna, N. O., & Stasyk, O. V. (2016) · Studia Biologica · doi:10.30970/sbi.1001.470
Stress-induced metabolite release creates an ecological and evolutionary opportunity for restoring growth regulation
Green, R. J. (2018) · ResearchWorks at the University of Washington (University of Washington)
Cationic Amino Acid Transporter-1 (CAT-1) Promotes Fibroblast-Like Synoviocytes Proliferation and Cytokine Secretion by Taking Up L-Arginine in Rheumatoid ArthritisPreprint
Lü, Y., Hao, C., Yu, S., Ma, Z., Fu, X., Qin, M., Ding, M., Xu, Z., & Fan, L. (2021) · Research Square · doi:10.21203/rs.3.rs-1147918/v1
Immune Cell Metabolites as Fuel for Cancer Cells
Aggarwal, V., Rathod, S., Vashishth, K., & Upadhyay, A. (2022) · Springer eBooks · doi:10.1007/978-981-16-6226-3_6
Data from Arginase Therapy Combines Effectively with Immune Checkpoint Blockade or Agonist Anti-OX40 Immunotherapy to Control Tumor Growth
Badeaux, M. D., Rolig, A. S., Agnello, G., Enzler, D., Kasiewicz, M. J., Priddy, L., Wiggins, J. F., Muir, A., Sullivan, M. R., Cleef, J. V., et al. (2023) · doi:10.1158/2326-6066.c.6550171
Data from Arginase Therapy Combines Effectively with Immune Checkpoint Blockade or Agonist Anti-OX40 Immunotherapy to Control Tumor Growth
Badeaux, M. D., Rolig, A. S., Agnello, G., Enzler, D., Kasiewicz, M. J., Priddy, L., Wiggins, J. F., Muir, A., Sullivan, M. R., Cleef, J. V., et al. (2023) · doi:10.1158/2326-6066.c.6550171.v1
Biology of cancer: current insights and perspectives
Hakkimane, S. S., & Gaonkar, S. L. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-16034-9.00011-3
Determination of Eight Hub Genes and Functional Pathways Affecting both the Survival of Early- and Late-Stage Colon Cancer Patients
Duran, G. A. (2023) · Turkish Journal of Oncology · doi:10.5505/tjo.2023.4014
Effects of selective lactate dehydrogenase A inhibitors and their mechanism in neoplastic and non-neoplastic cells
Frańczak, M. (2024) · doi:10.5463/thesis.984
Amino acid deprivation vs. mainstream cancer therapeutics: exploring the potential and limitations
Pande, A. H., Prasad, Y. R., & Anakha, J. (2025) · Future Oncology · doi:10.1080/14796694.2025.2508134
CARS2 modulates cell malignant transformation induced by IFN-γ through manipulation of arginine metabolism in bovine mammary epithelial cells
Liang, Q., Miao, J. G., Sa, Q., Wang, Z., Wang, T., Ji, Z., Li, N., Huang, J., Li, F., & Lei, L. (2025) · Animals and zoonoses. · doi:10.1016/j.azn.2025.07.002

Authors: Phillips, M. M., Sheaff, M. T., & Szlosarek, P. W.
Affiliations: St Bartholomew's Hospital (GB)
Queen Mary University of London (GB)
Corresponding author: Szlosarek, Peter W.
ORCID: Sheaff, Michael T.
Szlosarek, Peter W.
Venue: Cancer Research and Treatment
Publisher: Korean Cancer Association
Published: 2013-12-31
Volume: 45
Issue: 4
Pages: 251-262
ISSN: 1598-2998 (ISSN-L)
2005-9256
DOI: 10.4143/crt.2013.45.4.251
PMC: PMC3893322
OpenAlex: W2106712645
Cited by: 229
References: 105
Citations by year: 2026: 6 · 2025: 19 · 2024: 6 · 2023: 16 · 2022: 43 · 2021: 26 · 2020: 14 · 2019: 11 · 2018: 17 · 2017: 23 · 2016: 18 · 2015: 20 · 2014: 10
FWCI: 2.39
Type: journal article
Language: en
Open access: hybrid
doi.org
Licence: cc-by-nc
creativecommons.org/licenses/by-nc/3.0/ (tdm)
Locations: Cancer Research and Treatment (publishedVersion, cc-by-nc)
Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
PubMed Central (publishedVersion, cc-by-nc)
PubMed (publishedVersion)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Bacterial Cancer Therapy
Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
Keywords: arginine deprivation, argininosuccinate synthetase 1, argininosuccinate lyase, fumarate hydratase, arginine deiminase, ADI-PEG20, arginase, urea cycle enzymes, epigenetic silencing, melanoma, hepatocellular carcinoma, glioblastoma, renal cell carcinoma, treatment response biomarkers, drug resistance, multimodal therapy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Targeting Arginine-Dependent Cancers with Arginine-Degrading Enzymes: Opportunities and Challenges

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks